{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:43:52Z","timestamp":1772163832260,"version":"3.50.1"},"reference-count":22,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2022,9,17]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is increasing evidence that vitamin D (VD) deficiency may increase individuals\u2019 risk of COVID-19 infection and susceptibility. We aimed to determine the relationship between VD deficiency and sufficiency and COVID-19 seropositivity within healthcare workers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study included an observational cohort of healthcare workers who isolated due to COVID-19 symptoms from 12 May to 22 May 2020, from the University Hospitals Birmingham National Health Service Foundation Trust. Data collected included SARS-CoV-2 seroconversion status, serum 25(OH)D\n                      <jats:sub>3<\/jats:sub>\n                      levels, age, body mass index (BMI), sex, ethnicity, job role and comorbidities. Participants were grouped into four VD categories: (1) Severe VD deficiency (VD&lt;30\u2009nmol\/L); (2) VD deficiency (30\u2009nmol\/L \u2264VD&lt;50\u2009nmol\/L); (3) VD insufficiency (50\u2009nmol\/L \u2264VD&lt;75\u2009nmol\/L); (4) VD sufficiency (VD\u226575\u2009nmol\/L).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      When VD levels were compared against COVID-19 seropositivity rate, a U-shaped curve was identified. This trend repeated when participants were split into subgroups of age, sex, ethnicity, BMI and comorbidity status. Significant difference was identified in the COVID-19 seropositivity rate between VD groups in the total population and between groups of men and women; black, Asian and minority ethnic (BAME) group; BMI&lt;30 (kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ); 0 and +1 comorbidities; the majority of which were differences when the severely VD deficient category were compared with the other groups. A larger proportion of those within the BAME group (vs white ethnicity) were severely VD deficient (p\n                      <jats:italic>&lt;<\/jats:italic>\n                      0.00001). A larger proportion of the 0 comorbidity subgroup were VD deficient in comparison to the 1+ comorbidity subgroup (p=0.046).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study has shown a U-shaped relationship for COVID-19 seropositivity in UK healthcare workers. Further investigation is required to determine whether high VD levels can have a detrimental effect on susceptibility to COVID-19 infection. Future randomised clinical trials of VD supplementation could potentially identify \u2018optimal\u2019 VD levels, allowing for targeted therapeutic treatment for those at risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2022-001258","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T12:52:54Z","timestamp":1664283174000},"page":"e001258","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers"],"prefix":"10.1136","volume":"9","author":[{"given":"Sebastian T","family":"Lugg","sequence":"first","affiliation":[{"name":"Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R","family":"Mackay","sequence":"additional","affiliation":[{"name":"Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aduragbemi A","family":"Faniyi","sequence":"additional","affiliation":[{"name":"Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian E","family":"Faustini","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne E","family":"Duffy","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hewison","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian M","family":"Shields","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1508-8362","authenticated-orcid":false,"given":"Dhruv","family":"Parekh","sequence":"additional","affiliation":[{"name":"Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex G","family":"Richter","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Scott","sequence":"additional","affiliation":[{"name":"Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"Thickett","sequence":"additional","affiliation":[{"name":"Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"2025083109330556000_9.1.e001258.1","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.3390\/nu7105392","article-title":"Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D","volume":"7","author":"Wei","year":"2015","journal-title":"Nutrients"},{"key":"2025083109330556000_9.1.e001258.2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0660-4"},{"key":"2025083109330556000_9.1.e001258.3","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051248"},{"key":"2025083109330556000_9.1.e001258.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206680"},{"key":"2025083109330556000_9.1.e001258.5","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2020.1804365"},{"key":"2025083109330556000_9.1.e001258.6","unstructured":"Office for National Statistics . Updating ethnic contrasts in deaths involving the coronavirus (COVID-19). England, 2021."},{"key":"2025083109330556000_9.1.e001258.7","doi-asserted-by":"crossref","DOI":"10.3390\/nu9030260","article-title":"Prevalence of vitamin D deficiency and its associations with skin color in pregnant women in the first trimester in a sample from Switzerland","volume":"9","author":"Richard","year":"2017","journal-title":"Nutrients"},{"key":"2025083109330556000_9.1.e001258.8","unstructured":"Ontario PH . Association of vitamin D status with COVID-19 incidence and outcomes, and health equity considerations, 2021."},{"key":"2025083109330556000_9.1.e001258.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3582"},{"key":"2025083109330556000_9.1.e001258.10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04234-2020"},{"key":"2025083109330556000_9.1.e001258.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113046","article-title":"Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients","volume":"494","author":"Cook","year":"2021","journal-title":"J Immunol Methods"},{"key":"2025083109330556000_9.1.e001258.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-020-0558-y"},{"key":"2025083109330556000_9.1.e001258.13","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/j.clnu.2020.12.008","article-title":"Failure of national antenatal vitamin D supplementation programme puts dark skinned infants at highest risk: a newborn bloodspot screening study","volume":"40","author":"Uday","year":"2021","journal-title":"Clin Nutr"},{"key":"2025083109330556000_9.1.e001258.14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5578\/tt.70027","article-title":"Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis","volume":"68","author":"Kerget","year":"2020","journal-title":"Tuberk Toraks"},{"key":"2025083109330556000_9.1.e001258.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3481"},{"key":"2025083109330556000_9.1.e001258.16","doi-asserted-by":"crossref","first-page":"e1187349","DOI":"10.1080\/19381980.2016.1187349","article-title":"Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?","volume":"8","author":"Grant","year":"2016","journal-title":"Dermatoendocrinol"},{"key":"2025083109330556000_9.1.e001258.17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bmjnph-2021-000250","article-title":"Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 symptom study APP","volume":"4","author":"Louca","year":"2021","journal-title":"BMJ Nutr Prev Health"},{"key":"2025083109330556000_9.1.e001258.18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S2213-8587(21)00051-6","article-title":"Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials","volume":"9","author":"Jolliffe","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025083109330556000_9.1.e001258.19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00320","article-title":"Role of fibroblast growth factor-23 in innate immune responses","volume":"9","author":"Fitzpatrick","year":"2018","journal-title":"Front Endocrinol"},{"key":"2025083109330556000_9.1.e001258.20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99952-z","article-title":"Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity","volume":"11","author":"Freitas","year":"2021","journal-title":"Sci Rep"},{"key":"2025083109330556000_9.1.e001258.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00653-2021"},{"key":"2025083109330556000_9.1.e001258.22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-22"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:33:15Z","timestamp":1756657995000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,9,27]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bmjresp-2022-001258"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001258","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.11.21264835","asserted-by":"object"}]},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}